-
1
-
-
0002313754
-
Epidemiology and comorbidity of migraine
-
In: Goadsby PJ, Silbertein SD, eds. Boston: Butterworth-Heinemann
-
Lipton RB, Stewart WF. Epidemiology and comorbidity of migraine. In: Goadsby PJ, Silbertein SD, eds. Headache. Boston: Butterworth-Heinemann, 1997: 75-97.
-
(1997)
Headache
, pp. 75-97
-
-
Lipton, R.B.1
Stewart, W.F.2
-
2
-
-
0346031709
-
Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain
-
Headache Classifiction Committee of the International Headache Society
-
Headache Classifiction Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1998; 8 (suppl 7): 1-96.
-
(1998)
Cephalalgia
, vol.8
, Issue.SUPPL. 7
, pp. 1-96
-
-
-
4
-
-
0030927625
-
A 40-year follow-up of school children with migraine
-
Bille B A 40-year follow-up of school children with migraine. Cephalalgia. 17:1997;488-491.
-
(1997)
Cephalalgia
, vol.17
, pp. 488-491
-
-
Bille, B.1
-
5
-
-
0029988603
-
A nosographic analysis of the migraine aura in a general population
-
Russell MB, Olesen J A nosographic analysis of the migraine aura in a general population. Brain. 119:1996;355-361.
-
(1996)
Brain
, vol.119
, pp. 355-361
-
-
Russell, M.B.1
Olesen, J.2
-
6
-
-
0028787008
-
Mitochondria, magnesium and migraine
-
Welch KMA, Ramadan NM Mitochondria, magnesium and migraine. J Neurol Sci. 134:1995;9-14.
-
(1995)
J Neurol Sci
, vol.134
, pp. 9-14
-
-
Welch, K.M.A.1
Ramadan, N.M.2
-
7
-
-
0029089247
-
Clinical spectrum of CADASIL: A study of 7 families
-
Chabriat H, Vahedi Ket al. Clinical spectrum of CADASIL: a study of 7 families. Lancet. 346:1995;934-939.
-
(1995)
Lancet
, vol.346
, pp. 934-939
-
-
Chabriat, H.1
Vahedi, K.2
-
8
-
-
0029651792
-
Analgesic headache
-
Olesen J Analgesic headache. BMJ. 310:1995;479-480.
-
(1995)
BMJ
, vol.310
, pp. 479-480
-
-
Olesen, J.1
-
9
-
-
0025811621
-
Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs
-
Hering R, Steiner TJ Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs. Lancet. 337:1991;1442-1443.
-
(1991)
Lancet
, vol.337
, pp. 1442-1443
-
-
Hering, R.1
Steiner, T.J.2
-
10
-
-
0029086431
-
The utility of the encephalogram in the evaluation of patients presenting with headache
-
Gronseth GS, Greenberg MK The utility of the encephalogram in the evaluation of patients presenting with headache. Neurology. 45:1995;1263-1267.
-
(1995)
Neurology
, vol.45
, pp. 1263-1267
-
-
Gronseth, G.S.1
Greenberg, M.K.2
-
11
-
-
0028453699
-
Migraine prevalence: A review of population-based studies
-
Stewart WF, Schechter A, Rasmussen BK. Migraine prevalence: a review of population-based studies. Neurology 1994; 44 (suppl 4): S17-23.
-
(1994)
Neurology
, vol.44
, Issue.SUPPL. 4
-
-
Stewart, W.F.1
Schechter, A.2
Rasmussen, B.K.3
-
12
-
-
0028100273
-
Prevalence of headache and migraine in schoolchildren
-
Abu-Arefeh I, Russell G Prevalence of headache and migraine in schoolchildren. BMJ. 309:1994;765-769.
-
(1994)
BMJ
, vol.309
, pp. 765-769
-
-
Abu-Arefeh, I.1
Russell, G.2
-
13
-
-
0028452080
-
Migraine heterogeneity: Disability, pain intensity, and attack frequency and duration
-
Stewart WF, Schechter A, Lipton RB Migraine heterogeneity: disability, pain intensity, and attack frequency and duration. Neurology. 44(suppl 4):1994;S24-39.
-
(1994)
Neurology
, vol.44
, Issue.SUPPL. 4
, pp. 24-39
-
-
Stewart, W.F.1
Schechter, A.2
Lipton, R.B.3
-
14
-
-
0025355959
-
Migraine-related stroke in the context of the International Headache Society Classification of head pain
-
Welch KMA, Levine SR Migraine-related stroke in the context of the International Headache Society Classification of head pain. Arch Neurol. 47:1990;458-462.
-
(1990)
Arch Neurol
, vol.47
, pp. 458-462
-
-
Welch, K.M.A.1
Levine, S.R.2
-
16
-
-
0031035487
-
Clinical neurophysiology of headache
-
In: Mathew NT, ed. Philadelphia: Saunders Company
-
Schoenen J. Clinical neurophysiology of headache. In: Mathew NT, ed. Neurologic clinics (advances in headache). Philadelphia: Saunders Company, 1997: 85-107.
-
(1997)
Neurologic Clinics (Advances in Headache)
, pp. 85-107
-
-
Schoenen, J.1
-
17
-
-
0030201086
-
Interictal cortical hyperexcitability in migraine patients demonstrated with transcranial magnetic stimulation
-
Van Der Kamp W, Maassen Van Den Brink A, Ferrari MD, Van Dijk JG Interictal cortical hyperexcitability in migraine patients demonstrated with transcranial magnetic stimulation. J Neurol Sci. 139:1996;106-110.
-
(1996)
J Neurol Sci
, vol.139
, pp. 106-110
-
-
Van Der Kamp, W.1
Maassen Van Den Brink, A.2
Ferrari, M.D.3
Van Dijk, J.G.4
-
19
-
-
0029012866
-
Brain stem activation in spontaneous human migraine attacks
-
Weiller C, May A, Limmroth Vet al. Brain stem activation in spontaneous human migraine attacks. Nat Med. 1:1995;658-660.
-
(1995)
Nat Med
, vol.1
, pp. 658-660
-
-
Weiller, C.1
May, A.2
Limmroth, V.3
-
20
-
-
0028960823
-
The nitric oxide hypothesis of migraine and other vascular headaches
-
Olesen J, Thomsen LL, Lassen LH, Olesen IJ The nitric oxide hypothesis of migraine and other vascular headaches. Cephalalgia. 15:1995;94-100.
-
(1995)
Cephalalgia
, vol.15
, pp. 94-100
-
-
Olesen, J.1
Thomsen, L.L.2
Lassen, L.H.3
Olesen, I.J.4
-
22
-
-
0028325495
-
Pathophysiology of the migraine aura: The spreading depression theory
-
Lauritzen M Pathophysiology of the migraine aura: the spreading depression theory. Brain. 117:1994;199-210.
-
(1994)
Brain
, vol.117
, pp. 199-210
-
-
Lauritzen, M.1
-
23
-
-
0020630304
-
Changes in regional cerebral blood flow during the course of classic migraine attacks
-
Lauritzen M, Skyhøj Olsen T, Lassen NA, Paulson OB Changes in regional cerebral blood flow during the course of classic migraine attacks. Ann Neurol. 13:1983;633-641.
-
(1983)
Ann Neurol
, vol.13
, pp. 633-641
-
-
Lauritzen, M.1
Skyhøj Olsen, T.2
Lassen, N.A.3
Paulson, O.B.4
-
24
-
-
0026683693
-
Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine
-
Moskowitz MA Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci. 13:1992;307-312.
-
(1992)
Trends Pharmacol Sci
, vol.13
, pp. 307-312
-
-
Moskowitz, M.A.1
-
25
-
-
0002635215
-
Pathophysiology of migraine: A disease of the brain
-
In: Goadsby PJ, Silbertstein SD, eds. Boston: Butterworth-Heinemann
-
Goadsby PJ. Pathophysiology of migraine: a disease of the brain. In: Goadsby PJ, Silbertstein SD, eds. Headache. Boston: Butterworth-Heinemann, 1997: 5-25.
-
(1997)
Headache
, pp. 5-25
-
-
Goadsby, P.J.1
-
27
-
-
0027258572
-
On serotonin and migraine: A clinical and pharmacological review
-
Ferrari MD, Saxena PF On serotonin and migraine: a clinical and pharmacological review. Cephalalgia. 13:1993;151-156.
-
(1993)
Cephalalgia
, vol.13
, pp. 151-156
-
-
Ferrari, M.D.1
Saxena, P.F.2
-
28
-
-
0001874834
-
Ergot alkaloids
-
In: de Wolff FA, ed. Amsterdam: Elsevier
-
Tfelt-Hansen P, Saxena PR, Ferrari MD. Ergot alkaloids. In: de Wolff FA, ed. Handbook of clinical neurology, vol 65: intoxications of the nervous system; part II. Amsterdam: Elsevier, 1995: 61-79.
-
(1995)
Handbook of Clinical Neurology, Vol 65: Intoxications of the Nervous System
, Issue.PART II.
, pp. 61-79
-
-
Tfelt-Hansen, P.1
Saxena, P.R.2
Ferrari, M.D.3
-
29
-
-
0029049743
-
Practice parameter: Appropriate use of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus
-
Report of the Quality Standards Subcommittee of the American Academy of Neurology
-
Report of the Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: appropriate use of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus. Neurology 1995; 45: 585-87.
-
(1995)
Neurology
, vol.45
, pp. 585-587
-
-
-
30
-
-
0001286363
-
Serotonin receptor involvement in the pathogenesis and treatment of migraine
-
In: Goadsby PJ, Silberstein SD, eds. Boston, Butterworth-Heinemann
-
Martin GR. Serotonin receptor involvement in the pathogenesis and treatment of migraine. In: Goadsby PJ, Silberstein SD, eds. Headache. Boston, Butterworth-Heinemann, 1997: 25-39.
-
(1997)
Headache
, pp. 25-39
-
-
Martin, G.R.1
-
31
-
-
0030272955
-
1B/D receptor agonist zolmitriptan (311C90): Are brain stem sites therapeutic target in migraine?
-
1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine? Pain. 67:1996;355-359.
-
(1996)
Pain
, vol.67
, pp. 355-359
-
-
Goadsby, P.J.1
Hoskin, K.L.2
-
32
-
-
0030914002
-
Rizatriptan has central antinociceptive effects against durally evoked reponses
-
Cumberbatch MJ, Hill RG, Hargreaves RJ Rizatriptan has central antinociceptive effects against durally evoked reponses. Eur J Pharmacol. 328:1997;37-40.
-
(1997)
Eur J Pharmacol
, vol.328
, pp. 37-40
-
-
Cumberbatch, M.J.1
Hill, R.G.2
Hargreaves, R.J.3
-
33
-
-
0027175057
-
Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption
-
Kaube H, Hoskin KL, Goadsby PJ Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption. Br J Pharmacol. 109:1993;788-792.
-
(1993)
Br J Pharmacol
, vol.109
, pp. 788-792
-
-
Kaube, H.1
Hoskin, K.L.2
Goadsby, P.J.3
-
34
-
-
0027419370
-
Clinical and experimental effects of sumatriptan in humans
-
Ferrari MD, Saxena PR Clinical and experimental effects of sumatriptan in humans. Trends Pharmacol Sci. 14:1993;129-134.
-
(1993)
Trends Pharmacol Sci
, vol.14
, pp. 129-134
-
-
Ferrari, M.D.1
Saxena, P.R.2
-
35
-
-
0031283073
-
1B-immunoreactivity within the human trigemino-cerebrovascular system: Implications for the discovery of new antimigraine drugs
-
1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs. Cephalgia. 17:1997;833-842.
-
(1997)
Cephalgia
, vol.17
, pp. 833-842
-
-
Longmore, J.1
Shaw, D.2
Hopkins, R.3
-
36
-
-
0026056238
-
Mode of action of the anti-migraine drug sumatriptan
-
Humphrey PPA, Feniuk W Mode of action of the anti-migraine drug sumatriptan. Trends Pharmacol Sci. 12:1991;444-446.
-
(1991)
Trends Pharmacol Sci
, vol.12
, pp. 444-446
-
-
Humphrey, P.P.A.1
Feniuk, W.2
-
37
-
-
0000682979
-
CP-122 288 blocks neurogenic inflammation, but is not effective in aborting migraine attacks: Results of two controlled trials
-
Roon K, Diener HC, Ellis Pet al. CP-122 288 blocks neurogenic inflammation, but is not effective in aborting migraine attacks: results of two controlled trials. Cephalalgia. 17:1997;245.
-
(1997)
Cephalalgia
, vol.17
, pp. 245
-
-
Roon, K.1
Diener, H.C.2
Ellis, P.3
-
38
-
-
85030338420
-
Migraine, ataxia, and epilepsy: A challenging spectrum of genetic determined calcium channelopathies
-
for the Dutch Migraine Genetics Research Group. in press
-
Terwindt GM, Ophoff RA, Haan J, Frants RR, Ferrari MD for the Dutch Migraine Genetics Research Group. Migraine, ataxia, and epilepsy: a challenging spectrum of genetic determined calcium channelopathies. Eur J Human Genet (in press).
-
Eur J Human Genet
-
-
Terwindt, G.M.1
Ophoff, R.A.2
Haan, J.3
Frants, R.R.4
Ferrari, M.D.5
-
39
-
-
0029119352
-
Increased familial risk and evidence of genetic factor in migraine
-
Russell MB, Olesen J Increased familial risk and evidence of genetic factor in migraine. BMJ. 311:1995;541-544.
-
(1995)
BMJ
, vol.311
, pp. 541-544
-
-
Russell, M.B.1
Olesen, J.2
-
41
-
-
0027306090
-
A gene for familial hemiplegic migraine maps to chronosome 19
-
Joutel A, Bousser MG, Biousse Vet al. A gene for familial hemiplegic migraine maps to chronosome 19. Nat Genet. 5:1993;40-45.
-
(1993)
Nat Genet
, vol.5
, pp. 40-45
-
-
Joutel, A.1
Bousser, M.G.2
Biousse, V.3
-
42
-
-
0031470730
-
Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity
-
Ducros A, Joutel A, Vahedi Ket al. Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity. Ann Neurol. 42:1997;885-890.
-
(1997)
Ann Neurol
, vol.42
, pp. 885-890
-
-
Ducros, A.1
Joutel, A.2
Vahedi, K.3
-
43
-
-
0000889365
-
For the DMGRG: Involvement of the familial hemiplegic migraine gene on 19p13 in migraine with and without aura
-
Terwindt GM, Ophoff RA, Sandkuijl LA, van Eijk R, Haan J, Frants RR, Ferrari MD, for the DMGRG: involvement of the familial hemiplegic migraine gene on 19p13 in migraine with and without aura. Cephalalgia 1997; 17: 332.
-
(1997)
Cephalalgia
, vol.17
, pp. 332
-
-
Terwindt, G.M.1
Ophoff, R.A.2
Sandkuijl, L.A.3
Van Eijk, R.4
Haan, J.5
Frants, R.R.6
Ferrari, M.D.7
-
44
-
-
0027361402
-
Drug therapy of migraine
-
Welch KMA Drug therapy of migraine. N Engl J Med. 329:1993;1476-1484.
-
(1993)
N Engl J Med
, vol.329
, pp. 1476-1484
-
-
Welch, K.M.A.1
-
45
-
-
0001980483
-
Drug treatment of migraine attacks
-
In: Goadsby PJ, Silberstein SD, eds. Boston: Butterworth-Heinemann
-
Ferrari MD, Haan J. Drug treatment of migraine attacks. In: Goadsby PJ, Silberstein SD, eds. Headache. Boston: Butterworth-Heinemann, 1997: 117-31.
-
(1997)
Headache
, pp. 117-131
-
-
Ferrari, M.D.1
Haan, J.2
-
46
-
-
0031025883
-
Prophylactic pharmacotherapy of migraine; some practical guidelines
-
In: Mathew NT, ed. Philadelphia: Saunders
-
Tfelt-Hansen P. Prophylactic pharmacotherapy of migraine; some practical guidelines. In: Mathew NT, ed. Neurologic clinics (advances in headache). Philadelphia: Saunders, 1997; 153-67.
-
(1997)
Neurologic Clinics (Advances in Headache)
, pp. 153-167
-
-
Tfelt-Hansen, P.1
-
47
-
-
0001466260
-
High-dose riboflavin as a novel prophylactic antimigraine therapy: Results from a double blind, randomized, placebo-controlled trial
-
Schoenen J, Jacquy J, Lenaerts M High-dose riboflavin as a novel prophylactic antimigraine therapy: results from a double blind, randomized, placebo-controlled trial. Cephalalgia. 17:1997;244.
-
(1997)
Cephalalgia
, vol.17
, pp. 244
-
-
Schoenen, J.1
Jacquy, J.2
Lenaerts, M.3
-
48
-
-
0030908941
-
Migraine prophylactic drugs: Proof of efficacy, utilization and cost
-
Ramadan NM, Schultz LL, Gilkey SJ Migraine prophylactic drugs: proof of efficacy, utilization and cost. Cephalalgia. 17:1997;73-80.
-
(1997)
Cephalalgia
, vol.17
, pp. 73-80
-
-
Ramadan, N.M.1
Schultz, L.L.2
Gilkey, S.J.3
-
50
-
-
85030338682
-
Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: A systematic review based on number needed to treat
-
in press
-
Tfelt-Hansen P. Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat. Cephalalgia (in press).
-
Cephalalgia
-
-
Tfelt-Hansen, P.1
-
51
-
-
0028868649
-
Migraine and cluster headache: Their management with sumatriptan: A critical review of the current clinical experience
-
Wilkinson M, Pfaffenrath V, Schoenen J, Deiner HC, Steiner TJ Migraine and cluster headache: their management with sumatriptan: a critical review of the current clinical experience. Cephalalgia. 15:1995;337-357.
-
(1995)
Cephalalgia
, vol.15
, pp. 337-357
-
-
Wilkinson, M.1
Pfaffenrath, V.2
Schoenen, J.3
Deiner, H.C.4
Steiner, T.J.5
-
52
-
-
0029127294
-
The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migrain
-
Tfelt-Hansen P, Henry P, Mulder LJ, Scheldewaert RG, Schoenen J, Chazot G The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migrain. Lancet. 346:1995;923-926.
-
(1995)
Lancet
, vol.346
, pp. 923-926
-
-
Tfelt-Hansen, P.1
Henry, P.2
Mulder, L.J.3
Scheldewaert, R.G.4
Schoenen, J.5
Chazot, G.6
-
54
-
-
0029857086
-
Pharmacokinetic and pharmacokynamic profiles of sumatriptan in migraine patients with headache recurrence or no response
-
Visser WH, Burggraaf J, Muller LM, Schoemaker RC, Fowler PA, Cohen AF, Ferrari MD Pharmacokinetic and pharmacokynamic profiles of sumatriptan in migraine patients with headache recurrence or no response. Clin Pharmacol Ther. 60:1996;452-460.
-
(1996)
Clin Pharmacol Ther
, vol.60
, pp. 452-460
-
-
Visser, W.H.1
Burggraaf, J.2
Muller, L.M.3
Schoemaker, R.C.4
Fowler, P.A.5
Cohen, A.F.6
Ferrari, M.D.7
-
55
-
-
0030473835
-
Chest symptoms after sumatriptan: A two-year clinical practice review in 735 consecutive migraine patients
-
Visser WH, Jaspers NMWH, de Vriend RHM, Ferrari MD Chest symptoms after sumatriptan: a two-year clinical practice review in 735 consecutive migraine patients. Cephalalgia. 16:1996;554-559.
-
(1996)
Cephalalgia
, vol.16
, pp. 554-559
-
-
Visser, W.H.1
Jaspers, N.M.W.H.2
De Vriend, R.H.M.3
Ferrari, M.D.4
-
56
-
-
0025765727
-
Migraine pain associated with middle cerebral artery dilation: Reversal by sumatriptan
-
Friberg L, Olesen J, Iversen HK, Sperling B Migraine pain associated with middle cerebral artery dilation: reversal by sumatriptan. Lancet. 338:1991;13-17.
-
(1991)
Lancet
, vol.338
, pp. 13-17
-
-
Friberg, L.1
Olesen, J.2
Iversen, H.K.3
Sperling, B.4
-
57
-
-
0028919156
-
Cerebral blood flow during migraine attacks without aura and effect of sumatriptan
-
Ferrari MD, Haan J, Blokland JAK, Minnee P, Zwinderman KH, Saxena PR Cerebral blood flow during migraine attacks without aura and effect of sumatriptan. Arch Neurol. 52:1995;135-139.
-
(1995)
Arch Neurol
, vol.52
, pp. 135-139
-
-
Ferrari, M.D.1
Haan, J.2
Blokland, J.A.K.3
Minnee, P.4
Zwinderman, K.H.5
Saxena, P.R.6
-
58
-
-
85088331016
-
A multinational investigation of the impact of subcutaneous sumatriptan
-
Heywood J, Bouchard J, Cortelli Pet al. A multinational investigation of the impact of subcutaneous sumatriptan. Pharmacoeconomics. 11(1):1997;11-50.
-
(1997)
Pharmacoeconomics
, vol.11
, Issue.1
, pp. 11-50
-
-
Heywood, J.1
Bouchard, J.2
Cortelli, P.3
-
61
-
-
0029824318
-
Rizatriptan vs sumatriptan in the acute treatment of migraine
-
for the Dutch/US Rizatriptan Study Group
-
Visser WH, Terwindt GM, Reines SA, Jiang K, Lines CR, Ferrari MD, for the Dutch/US Rizatriptan Study Group. Rizatriptan vs sumatriptan in the acute treatment of migraine. Arch Neurol 1996; 53: 1132-37.
-
(1996)
Arch Neurol
, vol.53
, pp. 1132-1137
-
-
Visser, W.H.1
Terwindt, G.M.2
Reines, S.A.3
Jiang, K.4
Lines, C.R.5
Ferrari, M.D.6
-
62
-
-
0002928496
-
Evidence for the improved efficacy and safety of electriptan compared with sumatriptan
-
Diener HC Evidence for the improved efficacy and safety of electriptan compared with sumatriptan. Cephalalgia. 17:1997;477.
-
(1997)
Cephalalgia
, vol.17
, pp. 477
-
-
Diener, H.C.1
-
63
-
-
0030769110
-
Double-blind, placebo-controlled, dose-finding study of rizatriptan (MK-462) in the acute treatment or migraine
-
Gijsman H, Kramer MS, Sargent Jet al. Double-blind, placebo-controlled, dose-finding study of rizatriptan (MK-462) in the acute treatment or migraine. Cephalalgia. 17:1997;647-651.
-
(1997)
Cephalalgia
, vol.17
, pp. 647-651
-
-
Gijsman, H.1
Kramer, M.S.2
Sargent, J.3
-
64
-
-
0030695880
-
Clinical efficacy and tolerability of 2·5 mg zolmiriptan for the acute treatment of migraine
-
on behalf of the 042 Clinical Trial Study Group
-
Solomon GD, Cady RK, Klapper JA, et al. on behalf of the 042 Clinical Trial Study Group. Clinical efficacy and tolerability of 2·5 mg zolmiriptan for the acute treatment of migraine NEurology 1997; 49: 1219-25.
-
(1997)
NEurology
, vol.49
, pp. 1219-1225
-
-
Solomon, G.D.1
Cady, R.K.2
Klapper, J.A.3
-
65
-
-
0030657702
-
Optimizing; the dose of zolmitriptan (Zomig,*311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study
-
on behalf of the 017 Clinical Trial Study Group
-
Rapoport AM, Ramadan NM, Adelman JU, et al. on behalf of the 017 Clinical Trial Study Group. Optimizing; the dose of zolmitriptan (Zomig,*311C90) for the acute treatment of migraine. a multicenter, double-blind, placebo-controlled, dose range-finding study. Neurology 1997; 49: 1210-18.
-
(1997)
Neurology
, vol.49
, pp. 1210-1218
-
-
Rapoport, A.M.1
Ramadan, N.M.2
Adelman, J.U.3
-
66
-
-
0031454716
-
Naratriptan is effective and well tolerated in the acute treatment of migraine: Results of a double-blind, placebo-controlled, crossover study
-
on behalf of the Naratriptan S2WA3003 Study Group
-
Mathew NT, Asgharnejad M, Peykamian M, Laurenza A, on behalf of the Naratriptan S2WA3003 Study Group. Naratriptan is effective and well tolerated in the acute treatment of migraine: results of a double-blind, placebo-controlled, crossover study. Neurology 1997; 49: 1485-90.
-
(1997)
Neurology
, vol.49
, pp. 1485-1490
-
-
Mathew, N.T.1
Asgharnejad, M.2
Peykamian, M.3
Laurenza, A.4
-
67
-
-
0028855297
-
Dihydroergotamine nasal spray
-
Gijsman HJ, Ferrari MD Dihydroergotamine nasal spray. Neurology. 45:1995;397-480.
-
(1995)
Neurology
, vol.45
, pp. 397-480
-
-
Gijsman, H.J.1
Ferrari, M.D.2
-
68
-
-
0030020852
-
A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine
-
Winner P, Ricalde O, Le Force B, Saper J, Margul B A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine. Arch Neurol. 53:1996;180-184.
-
(1996)
Arch Neurol
, vol.53
, pp. 180-184
-
-
Winner, P.1
Ricalde, O.2
Le Force, B.3
Saper, J.4
Margul, B.5
-
69
-
-
0030044447
-
Side effects of ergotamine
-
Meijler WJ Side effects of ergotamine. Cephalalgia. 16:1996;5-10.
-
(1996)
Cephalalgia
, vol.16
, pp. 5-10
-
-
Meijler, W.J.1
-
70
-
-
0026048813
-
Myocardial ischemia related to ergot alkaloids: A case report and literature review
-
Galer BS, Lipton RB, Solomon S, Newman LC, Spierings ELH Myocardial ischemia related to ergot alkaloids: a case report and literature review. Headache. 31:1991;446-451.
-
(1991)
Headache
, vol.31
, pp. 446-451
-
-
Galer, B.S.1
Lipton, R.B.2
Solomon, S.3
Newman, L.C.4
Spierings, E.L.H.5
|